Discover 889 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 889
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Location: Birmingham AL, Murfreesboro TN, Macon GA, Charlotte NC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 6 - 17
Code: NCT05723198
Phase3, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Birmingham AL, Columbus MS, Atlanta GA, New Albany MS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase3, Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Birmingham AL, Atlanta GA, Pensacola FL, Paducah KY,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06580314
Phase3, Recruiting
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Get alerts for new trials in your area by subscribing now
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
for
Acute Promyelocytic Leukemia (APL),
Location: Birmingham AL, Nashville TN, Augusta GA, Lexington KY,
Sponsor: Quetzal Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07504458
Phase3, Recruiting
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
for
Dystonia
Location: Birmingham AL, Atlanta GA, Nashville TN, Memphis TN,
Sponsor: Vima Therapeutics
Sex: All
Age: 18 - 70
Code: NCT07304089
Phase2, Recruiting
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
for
Growth Hormone Deficiency (GHD)
Location: Birmingham AL, Tallahassee FL, New Orleans LA,
Sponsor: Lumos Pharma
Sex: All
Age: 3 - 11
Code: NCT06948214
Phase3, Recruiting
New
Post-Prandial Carbohydrate Metabolism in Individuals With and Without Post-Bariatric Surgery Hypoglycemia (PBH)
for
Hypoglycemia, Hypoglycemia, Reactive, Bariatric Surgery
Location: Birmingham AL, Boston MA
Sponsor: Joslin Diabetes Center
Sex: All
Age: 18 - 70
Code: NCT07818707
Recruiting
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
for
Uncontrolled Gout
Location: Birmingham AL, Newnan GA, Marietta GA, Jackson TN,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT07388498
Phase3, Recruiting
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
for
Indolent Systemic Mastocytosis,
Location: Birmingham AL, Atlanta GA, Cincinnati OH, Durham NC,
Sponsor: Blueprint Medicines Corporation
Sex: All
Age: 18+
Code: NCT04910685
Phase2, Phase3, Recruiting
State of Hormones Impact Nociceptive Expression
for
Pain, Gender Identity
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 65
Code: NCT05787470
Recruiting
Remote Ischemic Conditioning Using the autoRIC
for
Ischemia-Reperfusion Injury
Location: Birmingham AL, Charlotte NC, Jacksonville FL,
Sponsor: CellAegis US, Inc.
Sex: All
Age: 18+
Code: NCT03318575
Recruiting
Cardiometabolic Health Intervention Using Movement-to-Music Exercise
for
Cardiometabolic Risk Factors in Adult Wheelchair Users
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT05606432
Recruiting
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
Location: Birmingham AL, Atlanta GA, Saint Louis MO, Columbus OH,
Sponsor: TopAlliance Biosciences
Sex: All
Age: 18+
Code: NCT04137900
Phase1, Recruiting
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors